Eliminating disparities in clinical trials
Tuesday, September 23, 2008: 2:00 PM-4:00 PM, Minn Marriott, 4th Floor - Pine/Cedar/Birch
Clinical trials are a critical resource for developing new life-saving drugs as well better prevention, diagnostic, and treatment methods. However, people with low income, the elderly, racial/ethnic minorities, women and those who live in rural areas represent the smallest percentage of clinical trial participants. Unfortunately, these same populations also bear a disproportionate burden of disease. The result is often that clinical research does not assess how treatments may differently affect members of different populations. Consequently:
Control Research Center at Baylor College of Medicine, EDICT is a collaboration of over 300 medical researchers, healthcare professionals, patient advocates, public health officials, and pharmaceutical company representatives. Nine working groups have developed over 30 policy recommendations in the following areas:
- The scientific quality of clinical research is lowered.
- The financial cost of clinical research is increased as it takes more time, effort, and money to recruit and retain adequate numbers of participants.
- Ultimately, social justice is not served as the fruits of biomedical research are not equitably distributed.
- Brings together representative stakeholders from the public, private, and non-profit sectors to develop policy recommendations that comprehensively address disparities in clinical trials.
- Emphasizes a systems approach to identifying both the root causes of disparities and the critical policymakers who can address them.
- Communicates policy recommendations to the widest possible audience using a creative and pro-active dissemination model.
- Reinvigorating regulation & policy related to disparities in clinical trials
- Collaboration with the pharmaceutical industry
- Fostering community involvement in clinical trials
- Involving biomedical publications in setting standards for inclusion in clinical trials
- Professional education for researchers, health care professionals, and members of Institutional Review Boards (IRBs)
- Reallocating research funding to avoid duplication and address disparities
- Enhancing public and community education about clinical trials
- Navigation and support for individuals in clinical trials
- Assuring insurance coverage (private insurance, Medicare, Medicaid, and SCHIP) for costs of participating in clinical trials
![[ Visit Client Website ]](images/banner.jpg)